CITIUS PHARMAC (Germany) Analysis

CITIUS Stock Analysis Notes

The company recorded a loss per share of 0.19. CITIUS PHARMAC DL had not issued any dividends in recent years. The entity had 25:1 split on the 29th of August 2024. Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products targeting medical needs with a focus on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey. CITIUS PHARMAC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10 people. For more info on CITIUS PHARMAC DL please contact the company at 908 967 6677 or go to http://www.citiuspharma.com.

CITIUS PHARMAC DL Investment Alerts

CITIUS Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 186.2 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate CITIUS PHARMAC's market, we take the total number of its shares issued and multiply it by CITIUS PHARMAC's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Technical Drivers

As of the 15th of December 2024, CITIUS PHARMAC shows the risk adjusted performance of (0.14), and Mean Deviation of 4.81. CITIUS PHARMAC DL technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm CITIUS PHARMAC DL information ratio, maximum drawdown, potential upside, as well as the relationship between the treynor ratio and value at risk to decide if CITIUS PHARMAC DL is priced favorably, providing market reflects its regular price of 3.29 per share.

CITIUS PHARMAC DL Price Movement Analysis

CITIUS PHARMAC Outstanding Bonds

CITIUS PHARMAC Predictive Daily Indicators

CITIUS PHARMAC Forecast Models

CITIUS PHARMAC's time-series forecasting models are one of many CITIUS PHARMAC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary CITIUS PHARMAC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how CITIUS PHARMAC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling CITIUS shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as CITIUS PHARMAC. By using and applying CITIUS Stock analysis, traders can create a robust methodology for identifying CITIUS entry and exit points for their positions.

When running CITIUS PHARMAC's price analysis, check to measure CITIUS PHARMAC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CITIUS PHARMAC is operating at the current time. Most of CITIUS PHARMAC's value examination focuses on studying past and present price action to predict the probability of CITIUS PHARMAC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CITIUS PHARMAC's price. Additionally, you may evaluate how the addition of CITIUS PHARMAC to your portfolios can decrease your overall portfolio volatility.